Annual Revenue
N/A
December 31, 2023
Summary
- ENVB annual revenue is not available.
Performance
ENVB Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Revenue
N/A
September 30, 2024
Summary
- ENVB quarterly revenue is not available.
Performance
ENVB Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
September 30, 2024
Summary
- ENVB TTM revenue is not available.
Performance
ENVB TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ENVB Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ENVB Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Enveric Biosciences Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $9.60 M(+5.9%) | $38.83 M(-2.7%) |
| Dec 2019 | $39.91 M(-7.2%) | $9.06 M(-0.9%) | $39.91 M(-3.0%) |
| Sep 2019 | - | $9.15 M(-16.9%) | $41.13 M(-3.4%) |
| Jun 2019 | - | $11.02 M(+3.1%) | $42.56 M(-0.1%) |
| Mar 2019 | - | $10.69 M(+3.9%) | $42.62 M(-0.9%) |
| Dec 2018 | $43.00 M(-11.5%) | $10.28 M(-2.8%) | $43.00 M(-2.7%) |
| Sep 2018 | - | $10.58 M(-4.5%) | $44.17 M(-4.2%) |
| Jun 2018 | - | $11.08 M(+0.1%) | $46.12 M(-2.5%) |
| Mar 2018 | - | $11.06 M(-3.4%) | $47.32 M(-2.6%) |
| Dec 2017 | $48.59 M(+34.4%) | $11.45 M(-8.6%) | $48.59 M(-1.9%) |
| Sep 2017 | - | $12.53 M(+2.1%) | $49.53 M(+5.3%) |
| Jun 2017 | - | $12.27 M(-0.6%) | $47.05 M(+13.5%) |
| Mar 2017 | - | $12.34 M(-0.4%) | $41.47 M(+14.7%) |
| Dec 2016 | $36.15 M(+78.4%) | $12.39 M(+23.1%) | $36.15 M(+52.1%) |
| Sep 2016 | - | $10.06 M(+50.4%) | $23.76 M(+30.8%) |
| Jun 2016 | - | $6.69 M(-4.6%) | $18.16 M(+17.9%) |
| Mar 2016 | - | $7.01 M(+57.1%) | $15.41 M(+83.5%) |
| Dec 2015 | $20.26 M(+5980.8%) | - | - |
| Sep 2015 | - | $4.46 M(+13.5%) | $8.39 M(+113.5%) |
| Jun 2015 | - | $3.93 M(>+9900.0%) | $3.93 M(+377.7%) |
| Sep 2007 | - | $30.10 K(-91.7%) | $822.80 K(-4.4%) |
| Jun 2007 | - | $360.90 K(+0.3%) | $860.40 K(+45.2%) |
| Mar 2007 | - | $359.70 K(+398.9%) | $592.40 K(+77.8%) |
| Dec 2006 | $333.20 K(-72.1%) | $72.10 K(+6.5%) | $333.20 K(-21.0%) |
| Sep 2006 | - | $67.70 K(-27.1%) | $421.80 K(-32.5%) |
| Jun 2006 | - | $92.90 K(-7.6%) | $625.00 K(-35.0%) |
| Mar 2006 | - | $100.50 K(-37.5%) | $961.00 K(-19.4%) |
| Dec 2005 | $1.19 M(+7.8%) | $160.70 K(-40.7%) | $1.19 M(-21.9%) |
| Sep 2005 | - | $270.90 K(-36.8%) | $1.53 M(+4.5%) |
| Jun 2005 | - | $428.90 K(+29.2%) | $1.46 M(+15.3%) |
| Mar 2005 | - | $332.00 K(-32.9%) | $1.27 M(+14.6%) |
| Dec 2004 | $1.11 M(-12.9%) | $495.10 K(+141.2%) | $1.11 M(+15.7%) |
| Sep 2004 | - | $205.30 K(-12.6%) | $955.60 K(-12.5%) |
| Jun 2004 | - | $234.90 K(+37.6%) | $1.09 M(-1.4%) |
| Mar 2004 | - | $170.70 K(-50.5%) | $1.11 M(-12.7%) |
| Dec 2003 | $1.27 M | $344.70 K(+1.0%) | $1.27 M(-8.6%) |
| Sep 2003 | - | $341.30 K(+36.0%) | $1.39 M(-9.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2003 | - | $250.90 K(-24.5%) | $1.53 M(-12.6%) |
| Mar 2003 | - | $332.40 K(-28.4%) | $1.75 M(-5.8%) |
| Dec 2002 | $1.86 M(+15.7%) | $464.00 K(-3.5%) | $1.86 M(+4.2%) |
| Sep 2002 | - | $480.90 K(+2.2%) | $1.78 M(+11.1%) |
| Jun 2002 | - | $470.60 K(+6.8%) | $1.60 M(-0.9%) |
| Mar 2002 | - | $440.50 K(+13.2%) | $1.62 M(+0.9%) |
| Dec 2001 | $1.60 M(-27.2%) | $389.10 K(+28.5%) | $1.60 M(-8.4%) |
| Sep 2001 | - | $302.70 K(-37.7%) | $1.75 M(-15.8%) |
| Jun 2001 | - | $485.90 K(+14.0%) | $2.08 M(-2.1%) |
| Mar 2001 | - | $426.10 K(-20.5%) | $2.12 M(-3.6%) |
| Dec 2000 | $2.20 M(+32.6%) | $536.00 K(-14.9%) | $2.20 M(+32.2%) |
| Sep 2000 | - | $630.10 K(+18.9%) | $1.67 M(+60.8%) |
| Jun 2000 | - | $530.10 K(+4.8%) | $1.04 M(+104.8%) |
| Mar 2000 | - | $505.70 K(+534.5%) | $505.70 K(-69.9%) |
| Dec 1999 | $1.66 M(-1.1%) | - | - |
| Dec 1998 | $1.68 M(-39.6%) | $79.70 K(-80.1%) | $1.68 M(-32.3%) |
| Sep 1998 | - | $400.00 K(-42.9%) | $2.48 M(-13.9%) |
| Jun 1998 | - | $700.00 K(+40.0%) | $2.88 M(+3.6%) |
| Mar 1998 | - | $500.00 K(-43.3%) | $2.78 M(0.0%) |
| Dec 1997 | $2.78 M(+37.4%) | $881.20 K(+10.2%) | $2.78 M(+10.2%) |
| Sep 1997 | - | $800.00 K(+33.3%) | $2.52 M(+13.5%) |
| Jun 1997 | - | $600.00 K(+20.0%) | $2.22 M(+4.7%) |
| Mar 1997 | - | $500.00 K(-19.9%) | $2.12 M(+4.9%) |
| Dec 1996 | $2.02 M(+68.7%) | $624.20 K(+24.8%) | $2.02 M(+12.5%) |
| Sep 1996 | - | $500.00 K(0.0%) | $1.80 M(+12.5%) |
| Jun 1996 | - | $500.00 K(+25.0%) | $1.60 M(+14.3%) |
| Mar 1996 | - | $400.00 K(0.0%) | $1.40 M(+7.7%) |
| Dec 1995 | $1.20 M(+500.0%) | $400.00 K(+33.3%) | $1.30 M(+30.0%) |
| Sep 1995 | - | $300.00 K(0.0%) | $1.00 M(+42.9%) |
| Jun 1995 | - | $300.00 K(0.0%) | $700.00 K(+40.0%) |
| Mar 1995 | - | $300.00 K(+200.0%) | $500.00 K(+66.7%) |
| Dec 1994 | $200.00 K(+100.0%) | - | - |
| Nov 1994 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| Aug 1994 | $100.00 K | - | - |
| May 1994 | - | $100.00 K(0.0%) | $300.00 K(+50.0%) |
| Feb 1994 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| Nov 1993 | - | $100.00 K | $100.00 K |
FAQ
- What is the all time high annual revenue for Enveric Biosciences?
- What is the all time high quarterly revenue for Enveric Biosciences?
- What is the all time high TTM revenue for Enveric Biosciences?
What is the all time high annual revenue for Enveric Biosciences?
Enveric Biosciences all-time high annual revenue is $48.59 M
What is the all time high quarterly revenue for Enveric Biosciences?
Enveric Biosciences all-time high quarterly revenue is $12.53 M
What is the all time high TTM revenue for Enveric Biosciences?
Enveric Biosciences all-time high TTM revenue is $49.53 M